{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: However , a 38 % remission rate has been recently reported in refractory MCL treated with temsirolimus , a mTOR inhibitor . Here we had the opportunity to study a case of refractory MCL who had tumor regression two months after temsirolimus treatment , and a progression - free survival of 10 months .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| refractory MCL |\n| MCL |\n\nExplanation:\n\n* \"refractory MCL\" is mentioned twice, and it refers to a specific disease, so it is considered one entity.\n* \"MCL\" stands for Mantle Cell Lymphoma, which is the disease being treated in this case."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| MCL |\n\nExplanation:\n\n* \"refractory MCL\" is not a disease itself but a description of a disease's state, so it is not included in the table.\n* \"MCL\" is the only clear disease entity mentioned in the paragraph."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: However , a 38 % remission rate has been recently reported in refractory MCL treated with temsirolimus , a mTOR inhibitor . Here we had the opportunity to study a case of refractory MCL who had tumor regression two months after temsirolimus treatment , and a progression - free survival of 10 months .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| temsirolimus |\n\nExplanation:\n\nIn the given paragraph, the only chemical entity mentioned is \"temsirolimus\", which is a drug used to treat refractory Mantle Cell Lymphoma (MCL). Therefore, the markdown table above contains only one row with the chemical entity \"temsirolimus\"."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| temsirolimus |\n\nExplanation:\n\nIn the given paragraph, the only unambiguous chemical entity mentioned is \"temsirolimus\", which is a drug used to treat refractory Mantle Cell Lymphoma (MCL). Therefore, the markdown table above contains only one row with the chemical entity \"temsirolimus\".\n\nThe other terms mentioned in the paragraph, such as \"38 % remission rate\", \"refractory MCL\", and \"tumor regression\" are not chemical entities. The \"38 % remission rate\" refers to a medical statistic, \"refractory MCL\" is a medical condition, and \"tumor regression\" is a medical event. Therefore, these terms are not included in the table."}
  ]
}